DAWNZERA DIN 02571943
Health Canada record
| Active ingredient(s) | DONIDALORSEN (DONIDALORSEN SODIUM) 80 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B06AC09 DONIDALORSEN |
| Original market date | |
| Current status date | 28-Sep-2026 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 38368 | 2026-09-28 | New Drug Submission (NDS) |